International Stem Valuation
| ISCO Stock | USD 0.10 0.01 9.09% |
International Stem seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of International Stem Cell from evaluating the firm fundamentals such as Return On Equity of -6.92, current valuation of 5.11 M, and Return On Asset of -0.0685 as well as inspecting its technical indicators and probability of bankruptcy. . In general, most investors encourage obtaining undervalued assets and abandoning overvalued assets since, at some point, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that International Stem's price fluctuation is out of control at this time. Calculation of the real value of International Stem Cell is based on 3 months time horizon. Increasing International Stem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the International otc stock is determined by what a typical buyer is willing to pay for full or partial control of International Stem Cell. Since International Stem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of International OTC Stock. However, International Stem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.082 | Hype 0.1 |
The intrinsic value of International Stem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence International Stem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of International Stem Cell helps investors to forecast how International otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of International Stem more accurately as focusing exclusively on International Stem's fundamentals will not take into account other important factors: International Stem Total Value Analysis
International Stem Cell is currently forecasted to have valuation of 5.11 M with market capitalization of 1.68 M, debt of 4.31 M, and cash on hands of 586 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the International Stem fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.11 M | 1.68 M | 4.31 M | 586 K |
International Stem Investor Information
About 54.0% of the company shares are held by company insiders. The company has Price/Earnings (P/E) ratio of 103.12. International Stem Cell recorded a loss per share of 0.04. The entity had not issued any dividends in recent years. The firm had 1:150 split on the 29th of July 2015. International Stem Cell is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.International Stem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. International Stem has an asset utilization ratio of 145.09 percent. This suggests that the OTC Stock is making $1.45 for each dollar of assets. An increasing asset utilization means that International Stem Cell is more efficient with each dollar of assets it utilizes for everyday operations.International Stem Ownership Allocation
International Stem secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.International Stem Profitability Analysis
The company reported the previous year's revenue of 7.18 M. Net Loss for the year was (899 K) with profit before overhead, payroll, taxes, and interest of 4.24 M.About International Stem Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of International Stem Cell. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of International Stem Cell based exclusively on its fundamental and basic technical indicators. By analyzing International Stem's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of International Stem's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of International Stem. We calculate exposure to International Stem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of International Stem's related companies.International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California. International Stem operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 26 people.
8 Steps to conduct International Stem's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates International Stem's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct International Stem's valuation analysis, follow these 8 steps:- Gather financial information: Obtain International Stem's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine International Stem's revenue streams: Identify International Stem's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research International Stem's industry and market trends, including the size of the market, growth rate, and competition.
- Establish International Stem's growth potential: Evaluate International Stem's management, business model, and growth potential.
- Determine International Stem's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate International Stem's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
International Stem Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8 M | |
| Quarterly Earnings Growth Y O Y | -0.979 | |
| Retained Earnings | -110 M |
Other Information on Investing in International OTC Stock
International Stem financial ratios help investors to determine whether International OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Stem security.